Lymphoma
Showing 1–16 of 17 results
-
ALIQOPA (copanlisib) for injection, for intravenous use.
Read more -
Atriance (nelarabine) for injection
Read more -
BRUKINSA (zanubrutinib) capsules, for oral use.
Read more -
CALQUENCE (acalabrutinib) capsules, for oral use.
Read more -
Columvi (glofitamab) for injection
Read more -
COPIKTRA (duvelisib), capsules for oral use.
Read more -
EPKINLY (epcoritamab-bysp) injection
Read more -
GAZYVA (obinutuzumab) injection, for intravenous infusion.
Read more -
JAYPIRCA (pirtobrutinib)
Read more -
LUNSUMIO (mosunetuzumab-axgb) injection
Read more -
POLIVY (polatuzumab vedotin-piiq) for injection, for intravenous use.
Read more -
RYLAZE (asparaginase erwinia chrysanthemi (recombinant) rywn) injection
Read more -
ULTOMIRIS (ravulizumab-cwvz) injection
Read more -
VENCLEXTA (venetoclax) tablets, for oral use. Initial U.S. Approval: 2016
Read more -
XALKORI (crizotinib) capsules
Read more -
ZYDELIG (idelalisib) tablets, for oral use. Initial U.S. Approval: 2014
Read more
